Globus Medical GMED Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Globus Medical's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value?
- Globus Medical (GMED) reported share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value of $250.92M in Q1 2026.
- How has Globus Medical's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value changed year-over-year?
- Globus Medical's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value increased by 34.9% year-over-year, from $186.07M to $250.92M.
- What is the long-term trend for Globus Medical's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value?
- Over 4 years (2020 to 2024), Globus Medical's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value has grown at a 6.4% compound annual growth rate (CAGR), from $232.81M to $298.6M.